Targeting Inhibition of SmpB by Peptide Aptamer Attenuates the Virulence to Protect Zebrafish against Aeromonas veronii Infection
is an important pathogen of aquatic animals, wherein Small protein B (SmpB) is required for pathogenesis by functioning as both a component in stalled-ribosome rescue and a transcription factor in upregulation of virulence gene expression. Here a specific peptide aptamer PA-1 was selected from pepti...
Saved in:
Published in | Frontiers in microbiology Vol. 8; p. 1766 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
13.09.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | is an important pathogen of aquatic animals, wherein Small protein B (SmpB) is required for pathogenesis by functioning as both a component in stalled-ribosome rescue and a transcription factor in upregulation of virulence gene
expression. Here a specific peptide aptamer PA-1 was selected from peptide aptamer library by bacterial two-hybrid system employing pBT-SmpB as bait. The binding affinity between SmpB and PA-1 was evaluated using enzyme-linked immunosorbent assay. The key amino acids of SmpB that interact with PA-1 were identified. After PA-1 was introduced into
, the engineered strain designated as
(pN-PA-1) was more sensitive and grew slower under salt stress in comparison with wild type, as the disruption of SmpB by PA-1 resulted in significant transcription reductions of virulence-related genes. Consistent with these observations,
(pN-PA-1) was severely attenuated in model organism zebrafish, and vaccination of zebrafish with
(pN-PA-1) induced a strong antibody response. The vaccinated zebrafish were well protected against subsequent lethal challenges with virulent parental strain. Collectively, we propose that targeting inhibition of SmpB by peptide aptamer PA-1 possesses the desired qualities for a live attenuated vaccine against pathogenic
. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by: Dongsheng Zhou, Beijing Institute of Microbiology and Epidemiology, China This article was submitted to Infectious Diseases, a section of the journal Frontiers in Microbiology These authors have contributed equally to this work. Reviewed by: Liang Quanfeng, Shandong University, China; Xiangmin Lin, Fujian Agriculture and Forestry University, China; Chengxian Zhang, Johns Hopkins School of Medicine, United States |
ISSN: | 1664-302X 1664-302X |
DOI: | 10.3389/fmicb.2017.01766 |